Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Perioperative Risk Assessment in Pancreatic Surgery Using Machine Learning.
Pfitzner B, Chromik J, Brabender R, Fischer E, Kromer A, Winter A, Moosburner S, Sauer IM, Malinka T, Pratschke J, Arnrich B, Maurer MM. Pfitzner B, et al. Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:2211-2214. doi: 10.1109/EMBC46164.2021.9630897. Annu Int Conf IEEE Eng Med Biol Soc. 2021. PMID: 34891726
The landscape of genetic aberrations in myxofibrosarcoma.
Takeuchi Y, Yoshida K, Halik A, Kunitz A, Suzuki H, Kakiuchi N, Shiozawa Y, Yokoyama A, Inoue Y, Hirano T, Yoshizato T, Aoki K, Fujii Y, Nannya Y, Makishima H, Pfitzner BM, Bullinger L, Hirata M, Jinnouchi K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Okamoto T, Haga H, Ogawa S, Damm F. Takeuchi Y, et al. Among authors: pfitzner bm. Int J Cancer. 2022 Aug 15;151(4):565-577. doi: 10.1002/ijc.34051. Epub 2022 May 13. Int J Cancer. 2022. PMID: 35484982 Free article.
Targeted next-generation sequencing of circulating free DNA enables non-invasive tumor detection in myxoid liposarcomas.
Eisenhardt AE, Schmid A, Esser J, Brugger Z, Lausch U, Kiefer J, Braig M, Runkel A, Wehrle J, Claus R, Bronsert P, Leithner A, Liegl-Atzwanger B, Zeller J, Papini R, von Laffert M, Pfitzner BM, Koulaxouzidis G, Giunta RE, Eisenhardt SU, Braig D. Eisenhardt AE, et al. Among authors: pfitzner bm. Mol Cancer. 2022 Feb 14;21(1):50. doi: 10.1186/s12943-022-01523-x. Mol Cancer. 2022. PMID: 35164780 Free PMC article. No abstract available.
Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict).
Jank P, Lindner JL, Lehmann A, Pfitzner BM, Blohmer JU, Horst D, Kronenwett R, Denkert C, Schmitt WD. Jank P, et al. Among authors: pfitzner bm. Breast Cancer Res Treat. 2022 Jan;191(2):327-333. doi: 10.1007/s10549-021-06415-0. Epub 2021 Nov 16. Breast Cancer Res Treat. 2022. PMID: 34783927 Free PMC article.
TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms.
Schmiester M, Dolnik A, Kornak U, Pfitzner B, Hummel M, Treue D, Hartmann A, Agaimy A, Weyerer V, Lekaj A, Brakemeier S, Peters R, Öllinger R, Märdian S, Bullinger L, Striefler JK, Flörcken A. Schmiester M, et al. Among authors: pfitzner b. J Pathol Clin Res. 2021 Jan;7(1):3-9. doi: 10.1002/cjp2.187. Epub 2020 Nov 12. J Pathol Clin Res. 2021. PMID: 33180365 Free PMC article.
PARP-1 expression as a prognostic factor in Desmoid-type fibromatosis.
Bräutigam K, Lindner J, Budczies J, Pahl S, Kunitz A, Melcher I, Wust P, Nebrig M, Baur A, Denkert C, Pfitzner B. Bräutigam K, et al. Among authors: pfitzner b. Ann Diagn Pathol. 2020 Feb;44:151442. doi: 10.1016/j.anndiagpath.2019.151442. Epub 2019 Dec 13. Ann Diagn Pathol. 2020. PMID: 31855806
36 results